This sextuple board certified expert in cardiology is fellowship trained and has been practicing for almost the past decade. A member of both the American College of Cardiology and the American Heart Association, this expert currently serves as an Assistant Professor of Medicine at a major medical university. He is also the Director of Vascular imaging at the same institution....
Litigation Guides / Medtronic HeartWare Recalls: A Guide for Attorneys
Medtronic HeartWare Recalls: A Guide for Attorneys
For the past year, Medtronic, a medical device company, has been receiving complaints concerning products from its HeartWare Ventricular Assist Device (HVAD) System. The devices, which are designed to help the heart deliver blood to the rest of the body, are for patients in heart issue recovery or destination therapy for unplanned transplants. The devices are also used in patients who have undergone cardiac transplants and are at risk of death from end-stage left ventricular heart failure. More recently, the FDA has issued two separate recalls on Medtronic HeartWare products. Given the product’s vital medical usage, complications or malfunctions can have high stakes implications for patients. Though no related litigation is in motion yet, these recalls will certainly prompt injured parties to seek out justice. For attorneys pursuing Medtronic HeartWare litigation, this is what you need to know.
Recent Medtronic HeartWare Recalls
In April 2020, Medtronic sent out a safety alert to physicians and healthcare professionals warning them of dangers with the HeartWare HVAD Pump Outflow Graft and Outflow Graft Strain Relief devices. The following month, the U.S. Food and Drug Administration issued a Class I recall, the most serious type of recall, of the devices, citing the potential for serious injuries or death. Likewise, in December 2020, Medtronic sent out another alert, this time for its HVAD Pump Implant Kit, after receiving complaints of serious injuries and deaths. In March 2021, the FDA issued another Class I recall on the kits.
Medtronic HeartWare HVAC System Product Details & Risks
Medtronic’s HeartWare products are ventricular assist devices—mechanical pumps that support the heart and blood flow for those with weakened hearts. The devices are surgically implanted and connected to an external control unit. Last year’s recall of Medtronic’s HeartWare HVAD Pump Outflow Graft and Outflow Graft Strain Relief devices was issued because it was discovered that the outflow graft of the HVAD Pump may tear and the strain relief screw may break during assembly. The defect, however, might not be observed until during or after the pre-implant pump assembly and attachment to the HVAD pump. Medtronic’s letter to physicians provided additional steps for assembly and attachment to reduce the risk of damage during the assembly procedure, stressing that no further action is needed for patients already implanted with the pump since the damage applies to the pre-implant procedure.
Medtronic HeartWare Patient Complaints
Out of approximately the 22,000 HVAD pumps distributed through March 5, 2020, Medtronic had received 92 complaints related to the pre-implant assembly process and the associated outflow graft tears and strain relief screw damage. Complications related to outflow graft tears resulted in 54 complaints, including two deaths, resulting from peri-operative and post-operative bleeding. There were 38 complaints related to broken strain relief screws, with product damage identified prior or during the implant in 74 cases and post-implant in 18 cases. No harm related to damaged strain relief screws were yet reported. According to the FDA, the use of these defective products can cause dizziness, loss of consciousness, bleeding, fluid buildup around the heart, the need for additional medical procedures, and/or death.
Medtronic HVAD Pump Implant Kit Danger
By December 2020, Medtronic announced another potential danger, this time with its HVAD Pump Implant Kits, due to the device failing to start, restate, or delay in restarting once the pump stops. Medtronic sent out letters instructing health care providers how to avoid unnecessary pump stops and informing patients to contact their Ventricular Assist Device coordinator prior to any controller exchanges of the device. According to the FDA’s recently issued Class I recall, the delay or failure of these kits to start or restart can occur at any time – during preimplant testing, during the implant, or post-implant, and could cause serious harm such as heart attack, worsening heart failure, the need for additional procedures and hospitalizations, and/or death. There have been 29 complaints about this issue, with two deaths reported.
Strategic Research for Medtronic Litigation
The severity of these recalls and the potential dangers of Medtronic products leave the issue ripe for mass tort litigation. Although no lawsuits specific to these products have been filed just yet, attorneys have certainly expressed their interest in filing suits on behalf of those affected. And if prior Medtronic lawsuits are any indicator—such as its $54.5 million settlement reached in November 2018 to resolve allegations that it misled its investors about the safety of its heart pumps—it is likely any future litigation will be both complex and costly.
For attorneys interested in representing potential plaintiffs, Expert Institute offers services to make complex litigation easier. Our strategic research service provides an in-depth report on the device in question, including a comprehensive overview of the product’s history, development, and risk factors for injury. With access to relevant studies and research publications of leading industry experts, attorneys have all the necessary resources to make an informed decision about how to proceed with any potential case.
Mass Tort Prep for Medtronic Matters
Expert Institute also offers the Mass Tort Accelerator service which helps attorneys evaluate and strategize their intake procedures for potential plaintiffs in multi-plaintiff, large-scale cases. Attorneys can commission a bespoke client intake rubric to comprehensively assess injuries, detect risk factors, and evaluate each client’s eligibility. A custom intake rubric will also help attorneys identify any missing medical records—all before taking on their case. Our physicians are also available to aid with the evaluation of each plaintiff case’s strengths, weaknesses, and potential outcomes. Through these comprehensive consultative tools, attorneys have the informed guidance to zero-in on the most meritorious case for the purposes of a bellwether trial. This type of careful evaluation of plaintiff cases will be especially valuable for a mass tort on the scale of future Medtronic litigation.